Answers are grounded in this paper and cite their sources.
Genetics should now be part of everyday clinical epilepsy practice. Good data exist to provide empiric risks based on epilepsy syndrome diagnosis. Investigation of the molecular basis of some epilepsies is now a practical clinical task and is of clear value to the patient and family. In some cases, specific therapeutic decisions can now be made based on genetic findings, and this scenario of precision therapy is likely to increase in the coming years.
No takes yet. Share an insight, caveat, or question.
Samuel F. Berkovic (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: